IDEXX Laboratories

IDEXX Laboratories EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of IDEXX Laboratories (IDXX) as of Nov 7, 2026 is 40.59 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 34.26 % — a change of 18.47% (higher).

EBIT/Assets

40.59 %

YoY

18.47%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of IDEXX Laboratories is 2025 40.59 % . Operating Income to Assets Ratio (EBIT/Assets) of IDEXX Laboratories was 2024 34.26 % . It decreases by 18.47% higher compared to the previous year.

The IDEXX Laboratories EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
31.96 USD
Jan 1, 2019
30.17 USD
Jan 1, 2020
30.27 USD
Jan 1, 2021
38.24 USD
Jan 1, 2022
32.72 USD
Jan 1, 2023
33.66 USD
Jan 1, 2024
34.26 USD
Jan 1, 2025
40.59 USD
The IDEXX Laboratories EBIT/Assets history
YEAREBIT/AssetsYoY
40.59 %+18.47%
34.26 %+1.80%
33.66 %+2.85%
32.72 %-14.44%
38.24 %+26.34%
30.27 %+0.33%
30.17 %-5.60%
31.96 %+32.58%
24.11 %+5.35%
22.88 %+12.53%
20.33 %+8.15%
18.80 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IDEXX Laboratories Stock analysis

What does IDEXX Laboratories do? The history of IDEXX Laboratories Inc began in 1983 when a research team from the University of Maine developed technology for the automatic analysis of animal blood. The first products were soon sold and the company grew rapidly. Today, IDEXX is a leading global provider of veterinary diagnostic and IT solutions, recognized by customers in over 175 countries. IDEXX's business model is based on innovation and a comprehensive understanding of the needs of veterinarians and their patients. The company offers a wide range of products and solutions that make the diagnosis and treatment of animal diseases easier and more reliable. These include tests and devices for blood analysis, urine and stool diagnostics, as well as imaging, infection control, and cancer diagnostics. The company has several divisions that focus on different aspects of veterinary diagnostics. IDEXX Diagnostics is the largest business segment, offering veterinary lab services, diagnostic tests, and software solutions. IDEXX Water is a company specializing in the analysis of water samples and monitoring of environmental conditions. IDEXX Livestock, the newest division of IDEXX, provides veterinary solutions for agricultural and livestock operations. Key products of IDEXX include tests for parasites, infections, diabetes, and kidney function. The company has also developed some innovative products, such as SNAP tests, which provide fast and accurate results and can perform tests for various pathogens simultaneously. IDEXX is also a company committed to sustainability. The IDEXX Foundation was established in 2013 and has since donated over $32 million to local and global projects that aim to protect animals and the environment. Overall, IDEXX Laboratories Inc is a company specialized in veterinary diagnostic and IT solutions to support veterinarians in treating animals. The wide range of solutions and products, as well as the commitment to sustainability, make the company an important player in the market for veterinary diagnostics. IDEXX Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IDEXX Laboratories stock

Operating Income to Assets Ratio (EBIT/Assets) of IDEXX Laboratories is 40.59 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of IDEXX Laboratories changed from 34.26 % to 40.59 %, representing a 18.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) IDEXX Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s IDEXX Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — IDEXX Laboratories

All Key Metrics — IDEXX Laboratories